|Articles|July 1, 2020
- Pharmaceutical Executive-07-01-2020
- Volume 40
- Issue 7
Pharmaceutical Executive, July 2020 Issue (PDF)
Click the title above to open the Pharmaceutical Executive July 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 6 years ago
Will COVID-19 Usher in a New Era in Pharma Marketing?almost 6 years ago
Is Drug Production Heading Back to Europe From Abroad?almost 6 years ago
Central Focus: Targeting Unmet Need in CNSalmost 6 years ago
Will the Industry Rise to the Occasion?almost 6 years ago
How Oncologists are Coping with COVID-19about 6 years ago
Virtual Hiring of the C-Suiteabout 6 years ago
Culture and Compliance: Building a Culture of Business Ethicsabout 6 years ago
Fauci: Industry Will ‘Walk Away’ From COVID Price Controlsabout 6 years ago
A Sustainable Response to COVID-19about 6 years ago
Enterprise Leadership: Is Compliance Ripe for Disruption?Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Changing Reality of Pharmaceutical Commercialization in a Cold Chain-Driven Market
2
Vertex to Acquire Crinetics Pharmaceuticals for $10 Billion
3
Catalent Announces Expanded Partnership with Nanoscope Therapeutics
4
Reshoring Pharma and Biotech Manufacturing Ahead of This Summer’s Tariff Deadlines: Q&A with Ryan Last
5
